Severe hepatotoxicity after application of desloratadine and fluconazole.
Schöttker
Björn
B
Medizinische Poliklinik, University of Würzburg, Würzburg, Germany.
Dösch
Andreas
A
Kraemer
Doris M
DM
D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D000075202:Contraindications; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005335:Fever of Unknown Origin / Q000188:drug therapy; D015725:Fluconazole / Q000009:adverse effects*; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects*; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications / Q000628:therapy; D017336:Loratadine / Q000009:adverse effects* / Q000031:analogs & derivatives; D016399:Lymphoma, T-Cell / Q000150:complications / Q000628:therapy; D033581:Stem Cell Transplantation
D000935:Antifungal Agents; D039563:Histamine H1 Antagonists, Non-Sedating; D017336:Loratadine; D015725:Fluconazole; C121345:desloratadine